Vacirca Jeff L
SEC Form 4 insider trading activity
Vacirca Jeff L has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Aug 14, 2026.
On the most recent filing, Vacirca Jeff L is listed as Director at Caris Life Sciences, Inc. Inside the rolling window, Vacirca Jeff L reported 1 open-market purchase totaling $501K in CAI and no open-market sales.
Companies traded
Other insiders at CAI
Insider Buying
$501K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Vacirca Jeff L made?
Vacirca Jeff L has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.
Which companies does Vacirca Jeff L trade?
Vacirca Jeff L has filed SEC Form 4 disclosures for 1 company, including CAI.
When was Vacirca Jeff L's most recent SEC Form 4 filing?
Vacirca Jeff L's most recent SEC Form 4 filing on Tracefour is dated Aug 14, 2026.
What is Vacirca Jeff L's total buy and sell value in the current window?
Inside the rolling retention window, Vacirca Jeff L bought $501K and sold $0 based on SEC Form 4 filings.
What was Vacirca Jeff L's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 31,050 CAI shares on 2026-05-11, worth $501K, per SEC Form 4 filings.